Yupeng He

Company: Abbvie

Job title: Principal Scientist & Lead - Project Immunology Discovery Research

Bio:

Yupeng (David) He received his PhD in Microbiology-Immunology from the University of Washington and is currently a principal scientist and project leader in Immunology Discovery Research of AbbVie. David has over 20 years of biopharmaceutical industry experiences across therapeutic areas (immunology, oncology, virology) and therapeutic platforms (small-molecule, biologics, genetic/cell therapy).

Seminars:

Comparing & Contrasting the Different Myeloid Pathways for Functional Reprogramming to Identify Which Pathways are Better Targets 9:00 am

A comprehensive deep dive into the key molecular pathways, cell-surface receptors, intracellular regulators, and emerging targets involved in the reprogramming of myeloid cells. Rank different pathways by therapeutic potential, feasibility and safety, to ultimately improve and better identify functional reprogramming strategies. Review the major myeloid-targeted strategies being pursued to reprogram immune-suppressive cells (especially M2-like TAMs)…Read more

day: Pre-Conference Workshop Day